Terrence W. Norchi serves as Executive at Arch Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Terrence W. Norchi has executed 5 insider transactions totaling $1.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 31, 2023 involved purchasing 6,862 shares valued at $1.9K.
Terrence W. Norchi currently holds 6,862 shares of Arch Therapeutics, Inc. (ARTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Terrence W. Norchi has been a net buyer of ARTH stock. They have purchased $1.9K and sold $0 worth of shares.
Terrence W. Norchi's most recent insider trade was on Aug 31, 2023, when they purchased 6,862 shares at $0.28 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 19, 2018 | ARTH | $0 | Award | 360,000 | $N/A | Discretionary |
| May 3, 2016 | ARTH | $0 | Award | 1,130,000 | $N/A | Discretionary |
| Jun 26, 2013 | ARTH | $0 | Other | 1,419,076 | $N/A | Discretionary |